Latest filings (excl ownership)
15-12B
Securities registration termination
13 Apr 20
EFFECT
Notice of effectiveness
9 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Apr 20
POSASR
Automatic shelf registration (post-effective amendment)
2 Apr 20
POS AM
Prospectus update (post-effective amendment)
2 Apr 20
8-K
UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients
2 Apr 20
25-NSE
Exchange delisting
2 Apr 20
8-K
Other Events
31 Mar 20
8-K
Entry into a Material Definitive Agreement
16 Mar 20
8-K
Other Events
28 Feb 20
10-K
2019 FY
Annual report
27 Feb 20
8-K
Submission of Matters to a Vote of Security Holders
18 Dec 19
DEFA14A
Additional proxy soliciting materials
6 Dec 19
8-K
Other Events
25 Nov 19
DEFM14A
Proxy related to merger
15 Nov 19
10-Q
2019 Q3
Quarterly report
7 Nov 19
PREM14A
Preliminary proxy related to merger
1 Nov 19
8-K
Entry into a Material Definitive Agreement
10 Oct 19
DEFA14A
Additional proxy soliciting materials
10 Oct 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
8-K
Other Events
26 Jul 19
424B5
Prospectus supplement for primary offering
24 Jul 19
424B5
Prospectus supplement for primary offering
22 Jul 19
8-K
Entry into a Material Definitive Agreement
16 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 19
S-8
Registration of securities for employees
9 May 19
424B5
Prospectus supplement for primary offering
9 May 19
8-K
Entry into a Material Definitive Agreement
9 May 19
S-3ASR
Automatic shelf registration
9 May 19
10-Q
2019 Q1
Quarterly report
9 May 19
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
10-K
2018 FY
Annual report
7 Mar 19
8-K
Other Events
14 Dec 18
424B5
Prospectus supplement for primary offering
12 Dec 18
8-K
Termination of a Material Definitive Agreement
11 Dec 18
Latest ownership filings
SC 13D/A
NEW ENTERPRISE ASSOCIATES 13 LP
6 Apr 20
4
FOREST BASKETT
3 Apr 20
4
Edward T Mathers
3 Apr 20
4
Douglas A Treco
3 Apr 20
4
David Charles Lubner
3 Apr 20
4
Alonso Ricardo
3 Apr 20
4
Simon Read
3 Apr 20
4
Ramin Farzaneh-Far
3 Apr 20
4
Alexander Cumbo
3 Apr 20
4
TIMOTHY R PEARSON
3 Apr 20
4
John C King
3 Apr 20
4
Rajeev M. Shah
3 Apr 20
4
Robert Heft
3 Apr 20
4
Peter Kolchinsky
3 Apr 20
4
Aoife Brennan
3 Apr 20
4
Alonso Ricardo
18 Mar 20
4
Ramin Farzaneh-Far
18 Mar 20
4
Ramin Farzaneh-Far
20 Feb 20
SC 13G/A
Beneficial ownership report (amended)
10 Feb 20
4
Alonso Ricardo
21 Jan 20
4
Ramin Farzaneh-Far
16 Jan 20
4
Alonso Ricardo
18 Dec 19
4
Simon Read
18 Dec 19
4
Ramin Farzaneh-Far
18 Dec 19
4
Ramin Farzaneh-Far
18 Nov 19
4
Simon Read
18 Nov 19
SC 13G/A
Ra Pharmaceuticals, Inc.
8 Nov 19
4
Alonso Ricardo
17 Oct 19
4
Simon Read
17 Oct 19
4
Ramin Farzaneh-Far
17 Oct 19
SC 13D/A
Ra Pharmaceuticals, Inc.
17 Oct 19
SC 13D/A
Ra Pharmaceuticals, Inc.
11 Oct 19
4
Ramin Farzaneh-Far
16 Sep 19
4
Simon Read
16 Sep 19
4
Simon Read
27 Aug 19
4
Ramin Farzaneh-Far
27 Aug 19
4
Alonso Ricardo
27 Aug 19
4
Simon Read
18 Jul 19
4
Ramin Farzaneh-Far
16 Jul 19
4
Alonso Ricardo
25 Jun 19